Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Diane E. Sullivan is Director at Lexicon Pharmaceuticals. OQRO lists 4 transactions filed with the SEC under this name, the latest on Jun 4, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
1
Lexicon PharmaceuticalsLXRX
4 disclosures · May 2026 – Jun 2026
Jun 3, 202689Kdisclosed Jun 4
DetailsOfficial recordJun 3, 202689Kdisclosed Jun 4
DetailsOfficial recordMay 1, 202636Kdisclosed May 4
DetailsOfficial recordMay 1, 202643Kdisclosed May 4
DetailsOfficial recordOn the latest SEC Form 4, dated Jun 3, 2026, Diane E. Sullivan reported holding 126,122 shares of Lexicon Pharmaceuticals (LXRX). At the last close of $2 on Nov 13, 2026, that is about $226K. This is the stake disclosed in filings, not a net worth.
As of the latest filing on , Diane E. Sullivan reported holding 126,122 shares of Lexicon Pharmaceuticals (LXRX), worth about $226K at the last close of $2 (Nov 13, 2026). Holdings are also on file at Amarin Corp (AMRN); together they are worth about $235K.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals LXRX | 126,122 | 126K direct | $2 | $226K | Jun 3, 2026 |
| Amarin Corp AMRN | 836 | 836 direct | $11 | $9.5K | Apr 18, 2026 |
Is this Diane E. Sullivan’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
